KEY WORDS: Cancer, cancer prevention, multivitamins, vitamins, botanicals, medicinal mushrooms, probiotics I NDIVIDUALS born in the United States today have a 41% lifetime risk of being diagnosed with cancer, a sobering statistic that has urged the health care community to identify effective methods of cancer prevention. 1 Primary cancer prevention aims to reduce the risk of an individual developing cancer through the use of chemopreventive agents, the avoidance of exposure to environmental carcinogens, and the surgical removal of susceptible organs. 2 Secondary cancer prevention relies on early detection and screening measures to identify precancerous and/ or early stage tumors that are often more responsive to treatment than later stage tumors. Tertiary cancer prevention, often referred to as cancer control, aims to reduce the risk of recurrence, reduce the risk of metastasis, prevent second primary cancers, and prevent other cancerrelated complications. This article focuses on the use of natural products for primary cancer prevention. The article reviews the clinical trial evidence on the effectiveness of natural products for cancer prevention, including vitamins and minerals, botanicals, probiotics, and other agents of interest.
The use of natural products has increased in the United States. In 2007, approximately 18% of American adults reported using natural products beyond a basic multivitamin.
3 Individuals use natural products for a variety of health reasons, including treating and preventing disease, maintaining health, and promoting wellness. The evidence for this use is mixed and individuals do not use natural products in isolation. Many people use multiple natural products simultaneously and also engage in other health-related behaviors, such as dietary changes, physical activity, and the use of medications to prevent and treat disease. Factors associated with the use of natural products include prior use of natural products, higher age, higher education, and higher income. 4 There is a common perception that natural products are safe because they are ''natural,'' but a natural product is not necessarily a safe product. 5 Natural products are of particular interest as chemopreventive agents because of their potentially low toxicity profiles and potential effectiveness. 6 The National Center for Complementary and Alternative Medicine defines natural products as dietary supplements and include vitamins, minerals, probiotics, and herbal medicines. 3 The National Cancer Institute's Office for Cancer Complementary and Alternative Medicine (OCCAM) uses slightly different terminology for dietary supplements used as chemopreventive agents, referring to them as nutritional therapeutics, which include an assortment of nutrients, non-nutrients, and bioactive food components. 7 The efficacy of natural products as chemopreventive agents for primary and tertiary cancer prevention has not yet been established. Observational studies have suggested that various vitamins, minerals, and dietary components reduce the risk of developing specific cancers. However, clinical trials have not always supported these observations and/or the trials have not been conducted to test the efficacy of the natural products as chemopreventive agents. Current guidelines from the American Institute of Cancer Research, the American Cancer Society, and the Society for Integrative Oncology recommend against the use of dietary supplements for cancer prevention based on the current evidence. [8] [9] [10] [11] Many patients are not aware of these guidelines, or disregard the guidelines and use natural products with the intention of cancer prevention based on reports in the popular press and/or preliminary evidence.
Health care providers face many challenges when counseling patients on the use of natural products for cancer prevention. First, patients underreport use to their health care providers. 12 Reasons for this may include perceiving a lack of support for their use or fear of stigma from providers. Second, many health care providers believe that they are not qualified or sufficiently knowledgeable to counsel patients on the use of natural products.
13 Third, quality assurance of natural products is important.
14 Because the natural product industry is not tightly regulated by the US Food and Drug Administration, it can be challenging for health care providers to know whether a specific natural product is of high quality or not. Fourth, the evidence does not exist regarding the appropriate formulation, dose, duration, and cancer type for natural products.
This review provides an overview of commonly used natural products for cancer prevention, including a summary of the clinical trial literature to date. It is important to note that many of the results presented are based on post-hoc analyses, and are not the primary study outcomes, which may limit the generalizability and accuracy of the findings.
SUMMARY OF RESEARCH TO DATE

Vitamins and Minerals
Clinical trials examining vitamins and minerals as chemopreventive agents are summarized in Table 1 .
Multivitamins and combinations. Multivitamins and combination vitamins are dietary supplements comprised of two or more single agents. They are commonly used to both improve the nutritional status among nutrient-deficient populations and to hyper-supplement nutrientreplete populations. The results of clinical trials examining the effects of multivitamins as chemoprevention agents remain mixed.
Intervention trials in Linxian, China showed the importance of multivitamin supplementation in nutrition-deficient populations to reduce the risk of esophageal, stomach, and other cancers. 15 The benefit of supplementation in nutrient-replete populations is not as clear. The Supplementation en Vitamines et Mineraux Antioxydants (SU.VI. MAX) Trial showed that multivitamin use by men with normal prostate serum antigen (PSA) levels at baseline resulted in a reduced incidence of prostate cancer. However, among men with elevated PSA levels at baseline, multivitamin use was associated with a slightly increased incidence of prostate cancer. 16 The Physicians Health Study II, a large randomized clinical trial, continues to examine the effects of multivitamins in preventing prostate, colorectal, and other cancers in healthy men (ClinicalTrials. gov, NCT00270647). Results from the Iowa Women's Health Study of older women, suggest that there is an increase in overall mortality with the use of multivitamins, vitamin B6, iron, magnesium, zinc, and copper. 17 Single Agents Vitamin C. Vitamin C (ascorbic acid) is a watersoluble antioxidant that is an essential nutrient for humans. All fruits and vegetables contain vitamin C, with high concentrations found in citrus fruits, cruciferous vegetables, and dark leafy greens. The dietary reference intake (DRI) estimated average requirement is 60 mg per day for women and 75 mg per day for men. 18 In the 1970s, Linus Pauling promoted the use of vitamin C to prevent the common cold, and later for the treatment of cancer. His results remain controversial, but popular interest in vitamin C is still high. To date, clinical trials examining the effects of vitamin C on cancer prevention have not shown benefit. 19, 20 Vitamin E. Vitamin E is a fat soluble antioxidant that acts as a free-radical scavenger. Nuts, seeds, vegetable oils, and green leafy vegetables are food sources high in vitamin E. The DRI estimated average requirement for vitamin E is 12 mg/ 22.4 IU per day and it is commonly found in multivitamin formulations.
18 Thus far, clinical trials have shown no benefit of vitamin E as a chemoprevention agent. The Selenium and Vitamin E Cancer Prevention Trial (SELECT) found no benefit of vitamin E supplementation in men on the risk of prostate cancer; the trial was stopped early because of concern that vitamin E may increase the risk of prostate cancer. 21, 22 Updated results from the SELECT trial report that this concern was warranted. After 7 years mean follow-up, supplementation with 400 IUs of vitamin E significantly increased the risk of prostate cancer. 23 Similarly, well-designed clinical trials among women have not shown benefit of vitamin E on the prevention of breast, lung, or colon cancer. 24, 25 Selenium. Selenium is a necessary trace mineral involved in metabolism and is a potent antioxidant. Food sources high in selenium include Brazil nuts, brewers yeast, and vegetables grown in selenium-rich soil. Other food sources include fish, shellfish, red meat, grains, eggs, chicken, and garlic. The current DRI for selenium is 45 mg per day for adults. 18 Results from the initial trials in Linxian, China led many to believe that selenium could be a beneficial chemopreventive agent. Additional trials in China reported that selenium supplementation lowered the incidence of liver cancer. [26] [27] [28] However, results from clinical trials in the United States examining the effect of selenium supplementation on the incidence of cancer have been inconsistent. Early trials reported that selenium supplementation led to a significant decrease in the incidence of prostate cancer, but recent trials have reported no benefits from supplementation. 21, 22, [29] [30] [31] The latest results from the SELECT trial, however, report a possible increase in prostate cancer risk from selenium supplementation, although this increase did not reach statistical significance. 23 The Nutritional Prevention of Cancer Trial (NPCT) aimed to examine the effect of selenium on the incidence of several cancers and total cancer mortality. While selenium supplementation did not reduce the incidence of nonmelanoma skin cancer, it was found to be protective against prostate, lung, and colorectal cancers, and significantly reduced total cancer incidence and total cancer mortality.
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Beta-carotene. Beta-carotene, a nutrient found in leafy vegetables and fruit of yellow and orange pigment, is also an antioxidant and a free radical scavenger. Beta-carotene is also commonly found in multivitamin and combination antioxidant dietary supplement formulations. Observational studies have shown an inverse association between dietary beta-carotene intake and lung cancer incidence in populations at high risk of developing lung cancer. 34 Based on these observations, large-scale clinical trials were conducted to determine the ability of supplemental betacarotene to prevent lung cancer in high-risk populations. 35, 36 Contrary to the study hypotheses, two trials 36, 37 conducted among smokers and asbestos workers showed increased rates of lung cancer among those who received beta-carotene supplementation, and one of the trials also showed no significant difference in the incidence of prostate cancer. 37 Beta-carotene showed no effect in clinical trials testing its efficacy in skin and colon cancer prevention. 38, 39 These findings suggest a cautious approach to translating observational findings to the clinical setting, and reinforce the need for well-conducted clinical trials to demonstrate the benefit or harm of natural products for cancer prevention. The US Preventive Services Task Force has concluded that beta-carotene supplementation is unlikely to provide clinical benefits and may cause harm to some groups. 40 Vitamin D. Vitamin D is a fat-soluble vitamin that functions as a prohormone and regulates bone metabolism. The two major forms of vitamin D are vitamin D 3 (cholecalciferol) and vitamin D 2 (ergocalciferol). Vitamin D 3 is produced in the skin on exposure to ultraviolet radiation. Dietary sources of vitamin D include fatty fish (salmon, mackerel, sardines) and mushrooms. The Institute of Medicine recently published a report recommending a daily dose of 600 IUs of vitamin D. 41 A rapidly growing body of observational data suggests that higher vitamin D concentrations in the blood are associated with lower rates of multiple cancer types. [42] [43] [44] [45] It is currently unknown whether changing an individual's vitamin D concentration over time is beneficial, or at what point in the life course this change may be important for cancer prevention. To date, the results of four clinical trials [46] [47] [48] [49] have been published on the effects of combined vitamin D and calcium supplementation on cancer incidence and/or mortality. Of these, only one trial reported a decrease in cancer incidence resulting from vitamin D and calcium supplementation. 47 The other trials reported no impact on total cancer incidence, colorectal cancer, or cancer mortality resulting from combined vitamin D and calcium supplementation. 46, 48, 49 Many clinical trials are ongoing to examine the effects of vitamin D supplementation on surrogate biomarkers for cancer, as well as cancer incidence, some with doses as high as 25,000 IUs per week (ClinicalTrials.gov). The Vitamin D and Omega-3 Trial (VITAL) is an ongoing trial examining the effects of vitamin D and omega-3 supplementation in women on a host of outcomes, including cancer incidence (ClinicalTrials.gov, NCT01169259). Recruitment for the study began in January 2010 and is continuing through 2011.
Botanicals
Clinical trials examining botanicals as chemopreventive agents are described in Table 2 .
Green tea. There is a great deal of interest in the chemopreventive effects of green tea (Camellia sinensis), particularly in the catechin polyphenols components. Epidemiologic studies suggest that green tea consumption may reduce the risk of upper gastrointestinal tract cancers, lung cancer, hepatocellular cancer, and breast cancer in premenopausal women. 50, 51 The most commonly studied polyphenol in the clinical trial setting is epigallocatechin-3-gallate (EGCG). 51 Green tea catechins act on multiple pathways, including oxidative stress, carcinogen elimination, and enzyme inhibition. 51 Green tea has historically been ingested as a tea, but chemoprevention applications typically use concentrated extracts. Currently there is no consensus on the necessary dose or duration of use. Pilot clinical trials of green tea have focused on effects on surrogate biomarkers, and have suggested potential benefit in oral, skin, cervical, and prostate cancer prevention [52] [53] [54] [55] [56] ; these results need to be replicated. Trials are ongoing on the use of green tea for the prevention of breast cancer (www.ClinicalTrials.gov, NCT00917735, NCT00676793).
Soy. Soy, a complete protein source regarded as a staple of the East Asian diet, contains isoflavones that are of chemopreventive interest for their phytoestrogenic and antioxidant effects. Soy isoflavones can be administered via powder, extract, or in food; there is no standardized dose. The clinical trial evidence for soy as an effective chemopreventive strategy in food or supplement form has been mixed. There has been interest in the use of soy for breast cancer prevention, but little evidence suggests an effect. 57 There have been concerns of soy phytoestrogens acting as tumor promoters after a breast cancer diagnosis; a recent editorial suggests that this need not be a concern. 58 Studies on the effects of soy isoflavones on prostate cancer biomarkers, including PSA, have yielded mixed results. [59] [60] [61] An early phase study suggested that soy may decrease tumor progression in patients with low-grade prostate cancer.
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Curcumin. Curcumin, also known as turmeric or Curcuma longa, is a root commonly used as a culinary spice and is a major component of curry powders. Curcuminoids are the bioactive components of particular interest in chemoprevention for their antioxidant and anti-inflammatory effects, as well as their ability to inhibit activation of carcinogens by cytochrome enzymes. 63 There is no standardized dose at this time, and routes of administration can be via encapsulated powder, extracts, or in food. Curcumin is poorly absorbed and most research to date has focused on the prevention of colorectal cancer because of the direct contact with the colonic mucosa. There are limited clinical trial data. A primary prevention study suggested that curcumin may prevent the development of aberrant crypt foci in populations at high risk of colorectal cancer. 64 A small study in patients with adenomas suggested a possible reduction of polyp size and number with curcumin administration, whereas a study among patients with advanced colorectal cancer showed little effect on preventing disease progression. 65, 66 Fish Oil, Medicinal Mushrooms and Probiotics A summary of clinical trials examining the use of fish oil, medicinal mushrooms, and probiotics are found in Table 3 .
Fish Oils. Omega-3 fatty acids, such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are polyunsaturated fatty acids contained in fish oils. These compounds have been shown to have cardioprotective effects and are of interest for cancer prevention for their ability to inhibit the formation of proinflammatory and procarcinogenic eicosanoids, such as prostaglandins. Typical doses range from 1 to 4 g/day and are usually ingested via capsules or liquid form. Clinical trials to date suggest that EPA and DHA may protect against colorectal cancer in high-risk populations. 67, 68 VITAL is an ongoing trial assessing the potential benefits of fish oil supplementation on overall cancer risk (www. ClinicalTrials.gov, NCT01169259).
Medicinal mushrooms. Medicinal mushrooms, including Ganoderma lucidum, Coriolus versicolor, and maitake Grifola frondosa), are commonly found in Asian traditional pharmacopeias. Medicinal mushrooms may exert chemopreventive effects through their polysaccharides, which have been shown to enhance immune function, as well as their secondary metabolites, which may affect pathways related to apoptosis, angiogenesis, metastasis, cell cycle regulation, and signal transduction cascades. 69 Medicinal mushrooms are commonly ingested via encapsulated powders, extracts, and teas. Clinical trial research is in the early stages and preliminary studies have shown protective benefits including increasing immune function and preventing recurrence of cancer.
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Probiotics Probiotics, such as Lactobacillus sp., are live microorganisms found in dietary supplements and fermented food sources, such as yogurt and kefir, which possess possible chemopreventive benefits for the gastrointestinal tract. 73 Doses vary depending on the type of organism and are typically quantified by the number of living organisms per capsule, or colony forming unit (CFU) per capsule. Probiotics are hypothesized to confer their chemopreventive benefit by altering the gut microbiota and subsequently inhibiting/inducing colonic enzyme systems, controlling growth of harmful bacteria, improving immune function, and stimulating the production of active anticancer metabolites. In a trial of patients with a history of colorectal cancer, the occurrence of tumors with moderate and severe atypia was lower in the group receiving L. casei supplementation. 74 A clinical trial among healthy individuals suggested increased immune response with probiotics. 75 More research is needed to fully understand the chemopreventive role of probiotics.
IMPLICATIONS FOR ONCOLOGY CLINICIANS
Individuals use natural products for a variety of reasons, including cancer prevention and preventing cancer recurrence. It is important for health care providers to discuss use of natural products with their patients so that they can be counseled appropriately. Towards this aim, algorithms and guidelines have been developed for clinicians to use when counseling patients on the use of natural products and other complementary therapies. 76, 77 There are a number of reputable online resources for health care providers to use to investigate specific natural products, including the National Center for Complementary and Alternative Medicine (www.nccam.nih.gov), the National Cancer Based on evidence to date, it is not possible to recommend specific natural products as reliable and effective chemoprevention strategies. Clinicians should encourage their patients to use proven chemoprevention strategies and to follow lifestyle modifications to reduce their cancer risk. The reader is referred to the cancer prevention strategies published by the American Institute of Cancer Research.
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Clinicians can also suggest that their patients participate in clinical trials, when appropriate, to build the evidence base. Ongoing trials can be found at www.ClinicalTrials.gov.
For patients who are already using natural products, clinicians can inquire about their motivation for use, and counsel them using the current recommendations. Many patients use natural products with the goal of maintaining and/or improving overall health and wellness. This can be a good opportunity to discuss the benefits of other healthy behaviors, such as cancer screening, maintaining a healthy diet, being physically active, and maintaining a healthy body size.
For patients who chose to use natural products, clinicians can advise them to use high-quality products that are produced under high levels of quality assurance; although this can be difficult to do given that the natural product industry is not regulated.
IMPLICATIONS FOR SPECIAL POPULATIONS
Special populations, including individuals at high risk of developing cancer, individuals receiving cancer treatment, and individuals who have completed treatment, commonly use natural products. There is limited evidence to date on the effectiveness of natural products preventing cancer or cancer recurrence. Certain populations, including pediatric and geriatric populations, may be high users of natural products, using natural products for other health concerns. These patients should be counseled on potential effects, lack of effects, as well as drug interactions.
CONCLUSION
There is great potential for specific dietary supplements to be effective chemopreventive agents. However, to date some agents have shown promise while others have not. No agents have been proven to be effective against all cancers, and it is highly unlikely that such an agent will be identified. Until stronger evidence exists, clinicians can encourage their patients to engage in healthy behaviors, eg, cancer screening, maintaining a healthy diet, achieving a healthy body size, and being physically active.
